Alexandra Bruss

Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study

Andrés Yarur, Alexandra Bruss, Andrea Moosreiner et al. · Gastroenterology · 2023 · 64 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease

Ryan C. Ungaro, Andrés Yarur, Jacqueline Jossen et al. · Journal of Crohn s and Colitis · 2019 · 63 citations · Full text

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +17

Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases

Andrés Yarur, Alexandra Bruss, Snehal Naik et al. · Digestive Diseases and Sciences · 2019 · 48 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab

Andrés Yarur, Dermot McGovern, María T. Abreu et al. · Clinical Gastroenterology and Hepatology · 2022 · 30 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +10

Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission

Andrés Yarur, María T. Abreu, Parakkal Deepak et al. · The American Journal of Gastroenterology · 2023 · 24 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +16